1
00:00:11,697 --> 00:00:14,977
Speaker 1: You're listening to the Buck Sexton Show podcast, make sure

2
00:00:14,977 --> 00:00:17,977
Speaker 1: you subscribe to the podcast on the iHeartRadio app or

3
00:00:18,017 --> 00:00:19,737
Speaker 1: wherever you get your podcasts.

4
00:00:20,137 --> 00:00:22,497
Speaker 2: Hey, everybody, welcome to this episode of the Buck Brief.

5
00:00:22,497 --> 00:00:25,297
Speaker 2: We're joined by Julianna Mercer. She is a Marine Corps

6
00:00:25,377 --> 00:00:30,937
Speaker 2: veteran and the director of Public Advocates advocacy for Healing Breakthrough,

7
00:00:30,937 --> 00:00:32,817
Speaker 2: which you'll tell us about here us to do with

8
00:00:32,897 --> 00:00:37,257
Speaker 2: veterans and PTSD and treatment. Juliana, thanks for being here.

9
00:00:37,257 --> 00:00:38,537
Speaker 2: First of all, thank you for your service.

10
00:00:40,297 --> 00:00:41,817
Speaker 1: Thank you so great to be here. Buck.

11
00:00:42,457 --> 00:00:45,537
Speaker 3: All right, let's start with this. You're in the Marine Corps.

12
00:00:45,537 --> 00:00:51,257
Speaker 2: Now you're doing work to help fellow veterans through this organization,

13
00:00:51,577 --> 00:00:52,817
Speaker 2: Healing Breakthrough.

14
00:00:53,177 --> 00:00:55,297
Speaker 3: What is this entity? What does it do? What do

15
00:00:55,337 --> 00:00:56,097
Speaker 3: you focus on?

16
00:00:57,777 --> 00:01:01,257
Speaker 4: So, Healing Breakthrough has a mission to get MDMA assisted

17
00:01:01,337 --> 00:01:04,617
Speaker 4: therapy into the VA system for all veterans that can

18
00:01:04,657 --> 00:01:08,217
Speaker 4: benefit from it, and by benefit from it, it means

19
00:01:09,417 --> 00:01:15,337
Speaker 4: heal and solve their PTSD. MDMA just received their new

20
00:01:15,417 --> 00:01:21,017
Speaker 4: drug applification from the FDA with final results of seventy

21
00:01:21,057 --> 00:01:25,257
Speaker 4: one percent efficacy in eliminating a PTSD diagnosis and of

22
00:01:25,297 --> 00:01:29,897
Speaker 4: those that didn't get completely eliminate their diagnosis. They have

23
00:01:30,017 --> 00:01:33,017
Speaker 4: an eighty six percent reduction in symptoms. You compare that

24
00:01:33,097 --> 00:01:36,497
Speaker 4: to our current gold standards, where we're only seeing a

25
00:01:36,537 --> 00:01:39,297
Speaker 4: thirty percent reduction in symptoms. You can see why this

26
00:01:39,337 --> 00:01:41,177
Speaker 4: is something that's really exciting and we want to make

27
00:01:41,217 --> 00:01:43,177
Speaker 4: sure we get into the hands of veterans.

28
00:01:43,457 --> 00:01:46,057
Speaker 2: So if you could walk me through this a little bit.

29
00:01:46,457 --> 00:01:50,857
Speaker 2: MDMA this is like ecstasy is what people usually call it, right,

30
00:01:50,897 --> 00:01:56,777
Speaker 2: I mean as the street drug name, So go ahead, correct.

31
00:01:56,817 --> 00:02:03,057
Speaker 4: So there is MDMA found in ecstasy, but the pharmaceutical

32
00:02:03,257 --> 00:02:05,777
Speaker 4: that has been used for these clinical trials and that

33
00:02:05,817 --> 00:02:08,337
Speaker 4: it is going to be FDA approved, is very different

34
00:02:08,337 --> 00:02:11,777
Speaker 4: from the street drug. It's unadulterated and it's not mixed

35
00:02:11,817 --> 00:02:13,497
Speaker 4: with anything that you would find on the streets.

36
00:02:13,577 --> 00:02:17,017
Speaker 2: No sure or different. I'm just wondering how did this

37
00:02:17,817 --> 00:02:20,457
Speaker 2: come about? Like take me back to the beginning here.

38
00:02:20,497 --> 00:02:23,377
Speaker 2: I mean, for I have heard and you're hearing more

39
00:02:23,377 --> 00:02:25,297
Speaker 2: and more about this. People are talking about ayahuasca and

40
00:02:25,337 --> 00:02:28,537
Speaker 2: the veteran community. I have friends, particularly from the special

41
00:02:28,537 --> 00:02:32,417
Speaker 2: operations side, who have taken who have gone on these

42
00:02:33,697 --> 00:02:36,217
Speaker 2: you know, going to these sort of special medical clinics.

43
00:02:36,737 --> 00:02:39,017
Speaker 2: Some of them are outside of the US, and they

44
00:02:39,097 --> 00:02:42,177
Speaker 2: take drugs that are still not even It's not just

45
00:02:42,217 --> 00:02:45,337
Speaker 2: that they're not given here, they're still technically illegal here.

46
00:02:45,897 --> 00:02:48,857
Speaker 2: And some of them have had very powerful results. And

47
00:02:48,857 --> 00:02:52,377
Speaker 2: they're friends of mine, So I know something's going on here, right,

48
00:02:52,377 --> 00:02:56,777
Speaker 2: I mean, they're telling me they took aahuascar. There's another one.

49
00:02:57,057 --> 00:03:00,217
Speaker 2: I'm forgetting the name. What starts with an R. I think, yes,

50
00:03:00,777 --> 00:03:04,777
Speaker 2: I begain, I begain, thank you? I begin like, where

51
00:03:04,777 --> 00:03:07,337
Speaker 2: does this Where does this research? Where did this start?

52
00:03:07,577 --> 00:03:09,737
Speaker 2: How did we get into this realm where I mean,

53
00:03:09,777 --> 00:03:11,297
Speaker 2: you're doing public advocacy for this?

54
00:03:11,417 --> 00:03:11,657
Speaker 3: Now?

55
00:03:11,937 --> 00:03:13,937
Speaker 2: How did anyone figure out that some of these drugs

56
00:03:13,977 --> 00:03:17,217
Speaker 2: I think I begain comes from like a toad venom

57
00:03:17,257 --> 00:03:20,417
Speaker 2: basically that is distilled, Is that right or something like that?

58
00:03:21,777 --> 00:03:25,177
Speaker 4: One of these medications that's five MEODMT comes from the

59
00:03:25,217 --> 00:03:29,497
Speaker 4: toad venom I again comes from the African root. So

60
00:03:30,297 --> 00:03:34,217
Speaker 4: there you're seeing and hearing a lot of folks leaving

61
00:03:34,257 --> 00:03:37,497
Speaker 4: the country going to get healing through these therapies in

62
00:03:37,537 --> 00:03:40,897
Speaker 4: places where it's not illegal. I personally was able to

63
00:03:40,937 --> 00:03:43,817
Speaker 4: experience one of these therapies. One of the breakthrough therapies

64
00:03:44,497 --> 00:03:47,537
Speaker 4: outside of the US and was able to see almost

65
00:03:47,537 --> 00:03:50,297
Speaker 4: twenty years of trauma and grief just completely leave my

66
00:03:50,377 --> 00:03:53,617
Speaker 4: body overnight, and with the help of talk therapy, was

67
00:03:53,657 --> 00:03:55,817
Speaker 4: able to really get to the root cause of my

68
00:03:55,937 --> 00:04:00,737
Speaker 4: issues and was able to heal. And that is kind

69
00:04:00,777 --> 00:04:03,977
Speaker 4: of what got me on the track of doing this advocacy,

70
00:04:04,057 --> 00:04:08,217
Speaker 4: learning about these modalities. So back to MDMA, which is

71
00:04:08,217 --> 00:04:08,977
Speaker 4: the one that's going.

72
00:04:08,857 --> 00:04:09,937
Speaker 1: To be FDA approved.

73
00:04:10,697 --> 00:04:14,217
Speaker 4: It was formulated in nineteen twelve by Merk and it

74
00:04:14,617 --> 00:04:18,657
Speaker 4: was being used for talk therapy very successfully, but it

75
00:04:18,737 --> 00:04:24,257
Speaker 4: did leak out into the rave scene and was scheduled

76
00:04:24,297 --> 00:04:28,217
Speaker 4: by the DEA in the mid eighties, and so that

77
00:04:28,297 --> 00:04:32,217
Speaker 4: effective use was no our healthcare providers were no longer

78
00:04:32,257 --> 00:04:34,817
Speaker 4: able to use it. And so for the last thirty

79
00:04:34,897 --> 00:04:39,577
Speaker 4: years there's been an organization called maps now lycos that

80
00:04:39,617 --> 00:04:43,577
Speaker 4: has been making sure that the research doesn't get lost.

81
00:04:43,657 --> 00:04:45,977
Speaker 4: So it's taken thirty years for them to get this

82
00:04:46,377 --> 00:04:49,857
Speaker 4: through the FDA process, and we just saw the new

83
00:04:49,937 --> 00:04:53,857
Speaker 4: drug application get accepted and we're anticipating FDA approval for

84
00:04:54,177 --> 00:04:57,777
Speaker 4: MDMA assisted therapy in August of this year.

85
00:04:59,617 --> 00:05:03,177
Speaker 2: I mean, this is fascinating stuff. What I mean I

86
00:05:03,537 --> 00:05:06,297
Speaker 2: have so many questions. One of them is, how is

87
00:05:06,337 --> 00:05:09,457
Speaker 2: the medical community reacting to this so far?

88
00:05:09,657 --> 00:05:09,737
Speaker 1: Right?

89
00:05:10,057 --> 00:05:12,777
Speaker 2: Because these are you know, we've always known when it

90
00:05:12,777 --> 00:05:16,257
Speaker 2: comes to opiates, for example, that it's been known for

91
00:05:16,537 --> 00:05:19,177
Speaker 2: a very long time, centuries, if not a millennia, that

92
00:05:19,177 --> 00:05:23,217
Speaker 2: these things can be used for pain management, right, also

93
00:05:23,297 --> 00:05:25,937
Speaker 2: highly addictive and can be dangerous. But people generally don't

94
00:05:25,937 --> 00:05:28,377
Speaker 2: think of some of these other drugs, and specifically MDMA

95
00:05:28,497 --> 00:05:31,897
Speaker 2: as something that is therapy. It's so ingrained in the

96
00:05:31,937 --> 00:05:33,617
Speaker 2: public mind. This is a part, as you said, a

97
00:05:33,617 --> 00:05:37,137
Speaker 2: party drug, a rave drug, that this could help treat

98
00:05:37,217 --> 00:05:39,897
Speaker 2: and or even possibly in some cases, not all, but

99
00:05:39,937 --> 00:05:45,377
Speaker 2: some cure veterans of extreme PTSD that they have been

100
00:05:45,417 --> 00:05:47,457
Speaker 2: dealing with as a result of the wars we've been

101
00:05:47,457 --> 00:05:50,857
Speaker 2: fighting abroad. That's a lot i thing for people to

102
00:05:50,857 --> 00:05:53,177
Speaker 2: take in. How is the medical community reacting. Are there

103
00:05:53,457 --> 00:05:55,577
Speaker 2: are there big advocates for it? Are they scared they

104
00:05:55,577 --> 00:05:57,097
Speaker 2: don't want to go near it because the stuff is

105
00:05:57,377 --> 00:05:59,737
Speaker 2: technically illegal still?

106
00:06:00,497 --> 00:06:03,697
Speaker 4: Yeah, So I think the medical community and the community

107
00:06:03,697 --> 00:06:07,737
Speaker 4: at large is has been starting to be educated on

108
00:06:07,857 --> 00:06:09,897
Speaker 4: the great potential of these novel treatments.

109
00:06:10,177 --> 00:06:11,097
Speaker 1: They're also.

110
00:06:12,377 --> 00:06:16,257
Speaker 4: Destigmatizing through the veteran voices that you're hearing. So veterans

111
00:06:16,297 --> 00:06:18,457
Speaker 4: are coming home and they're touching their communities with these

112
00:06:18,497 --> 00:06:23,257
Speaker 4: voices and saying, after fifteen years of complex chronic PTSD,

113
00:06:24,057 --> 00:06:27,497
Speaker 4: this one illegal medication that I had to leave the

114
00:06:27,497 --> 00:06:32,697
Speaker 4: country for gave me twenty years worth of therapy. And

115
00:06:32,817 --> 00:06:36,697
Speaker 4: so the veteran voices helping to destigmatize We're also we

116
00:06:36,737 --> 00:06:39,537
Speaker 4: have folks inside of the VA at the top and

117
00:06:39,657 --> 00:06:44,257
Speaker 4: the bottom that are working to study these substances. They're

118
00:06:44,297 --> 00:06:49,737
Speaker 4: being studied at all of our higher ed institutions. Harvard, Yale,

119
00:06:49,977 --> 00:06:52,937
Speaker 4: Johns Hopkins is also studying these. So there's been a

120
00:06:53,017 --> 00:06:58,217
Speaker 4: lot more science behind it and a lot more education happening.

121
00:06:58,377 --> 00:07:04,177
Speaker 4: So people are starting to understand the potential use of

122
00:07:04,217 --> 00:07:07,177
Speaker 4: these and a lot of the science is also showing

123
00:07:07,257 --> 00:07:10,977
Speaker 4: us that there is minimal to little harm when you

124
00:07:11,097 --> 00:07:14,537
Speaker 4: use these substance correctly with the help of a mental

125
00:07:14,537 --> 00:07:15,257
Speaker 4: health care provider.

126
00:07:15,537 --> 00:07:16,817
Speaker 2: Let me ask you more about that in a second,

127
00:07:16,857 --> 00:07:18,737
Speaker 2: But just a word from our sponsor here, the Oxford

128
00:07:18,777 --> 00:07:21,017
Speaker 2: Gold Group. A lot of people are still on the

129
00:07:21,057 --> 00:07:23,657
Speaker 2: fence about whether they should own precious metals, and I

130
00:07:23,737 --> 00:07:25,857
Speaker 2: just think it's a smart thing to diversify and to

131
00:07:25,857 --> 00:07:29,497
Speaker 2: take action today to prepare for an uncertain future. Look

132
00:07:29,497 --> 00:07:32,497
Speaker 2: inflation's ticking up again. Look at gold over the last

133
00:07:32,537 --> 00:07:34,577
Speaker 2: thirty years. Has it gone up? Has it gone down?

134
00:07:34,697 --> 00:07:37,977
Speaker 2: The answer is very straightforward. Gold is something you want

135
00:07:37,977 --> 00:07:40,777
Speaker 2: to have on hand as part of your over all portfolio.

136
00:07:41,177 --> 00:07:43,137
Speaker 2: You can use it as a tangible currency in case

137
00:07:43,177 --> 00:07:45,777
Speaker 2: you have to bug out for some reason. Portfolio diversification,

138
00:07:45,937 --> 00:07:48,697
Speaker 2: a hedge against inflation. It's also a store of value

139
00:07:48,697 --> 00:07:51,817
Speaker 2: because historically gold increases over time. So if you're paying

140
00:07:51,857 --> 00:07:55,297
Speaker 2: attention to global events, particularly global economic events, now is

141
00:07:55,337 --> 00:07:58,097
Speaker 2: the time to have some gold and silver on hand.

142
00:07:58,457 --> 00:08:00,497
Speaker 2: Nobody can predict the future, but you don't want to

143
00:08:00,497 --> 00:08:02,537
Speaker 2: put your head in the sand either. The Oxford Gold

144
00:08:02,617 --> 00:08:04,737
Speaker 2: Group those are the pros I trust. That's who I've

145
00:08:04,777 --> 00:08:07,137
Speaker 2: bought my gold and silver from for years. They may

146
00:08:07,217 --> 00:08:09,377
Speaker 2: own in gold and silver. Easy and simple to understand.

147
00:08:09,417 --> 00:08:12,097
Speaker 2: Call the Oxford Gold Group right now. You may qualify

148
00:08:12,137 --> 00:08:14,617
Speaker 2: for up to ten thousand dollars in free precious medals.

149
00:08:14,857 --> 00:08:15,777
Speaker 3: They'll give you details.

150
00:08:15,857 --> 00:08:18,857
Speaker 2: Call them eight three three nine nine five gold eight

151
00:08:18,977 --> 00:08:22,257
Speaker 2: three three nine nine five go o LD. That's eight

152
00:08:22,257 --> 00:08:25,857
Speaker 2: three three nine nine to five Gold Juliana in terms

153
00:08:25,937 --> 00:08:30,137
Speaker 2: of the risks, and I guess, you know what, what

154
00:08:30,177 --> 00:08:32,617
Speaker 2: do the NA say? Are there naysayers about this? Are

155
00:08:32,657 --> 00:08:34,697
Speaker 2: there people who try to just dismiss this out of hand?

156
00:08:34,737 --> 00:08:37,977
Speaker 2: Do they say it's dangerous to be treating anybody, not

157
00:08:38,057 --> 00:08:40,817
Speaker 2: just veterans with MDMA. I'm sure there has to be

158
00:08:40,857 --> 00:08:45,817
Speaker 2: some bureaucratic or institutional pushback or is there.

159
00:08:47,457 --> 00:08:48,817
Speaker 1: There is? But it's minimal.

160
00:08:49,217 --> 00:08:51,617
Speaker 4: I'm on the hill every day talking to our legislators,

161
00:08:51,657 --> 00:08:54,217
Speaker 4: and when I'm able to explain to them the science

162
00:08:54,297 --> 00:08:57,177
Speaker 4: behind this, and I'm able to show them that this

163
00:08:57,337 --> 00:09:00,537
Speaker 4: is a treatment that has medical value, it's a lot

164
00:09:00,577 --> 00:09:02,697
Speaker 4: easier for them to wrap their heads around it. We

165
00:09:02,737 --> 00:09:05,657
Speaker 4: are still fighting the stigma of the you know, the

166
00:09:05,817 --> 00:09:09,897
Speaker 4: the sixties and seventies, the War on drugs, and are

167
00:09:10,177 --> 00:09:14,097
Speaker 4: our DEA telling us that these are Schedule one substances,

168
00:09:14,097 --> 00:09:17,577
Speaker 4: which means they hold no medical value. And so we're

169
00:09:17,577 --> 00:09:20,737
Speaker 4: finding out now that that is not true, and through

170
00:09:20,777 --> 00:09:24,577
Speaker 4: the science and research, we're able to start to help

171
00:09:24,617 --> 00:09:27,857
Speaker 4: people change their minds about the stories that we were

172
00:09:27,897 --> 00:09:30,497
Speaker 4: told that these had no medical use.

173
00:09:31,577 --> 00:09:32,697
Speaker 3: Is there any.

174
00:09:34,217 --> 00:09:36,737
Speaker 2: Change in legislation that may be coming that would address

175
00:09:37,457 --> 00:09:40,657
Speaker 2: the legality of this for medicinal use. And we've seen

176
00:09:40,697 --> 00:09:43,617
Speaker 2: something of a progression like that over the course of

177
00:09:43,617 --> 00:09:45,537
Speaker 2: many years with marijuana. And there used to be a

178
00:09:45,577 --> 00:09:47,457
Speaker 2: lot of talk, gosh, I think, like twenty years ago

179
00:09:47,497 --> 00:09:52,137
Speaker 2: now about medicinal marijuana for specifically glaucoma and some other conditions,

180
00:09:52,137 --> 00:09:53,417
Speaker 2: and some of the studies.

181
00:09:53,057 --> 00:09:55,137
Speaker 3: For it or that were in support of it.

182
00:09:55,657 --> 00:09:58,457
Speaker 2: Now marijuana has also just gone legal in a lot

183
00:09:58,497 --> 00:10:01,177
Speaker 2: of places at the state level. Is there an interest

184
00:10:01,337 --> 00:10:04,417
Speaker 2: in changing the law so that veterans have I mean

185
00:10:04,457 --> 00:10:06,297
Speaker 2: just the fact that they have to leave the country

186
00:10:06,337 --> 00:10:08,217
Speaker 2: to get this therapy. And I know it's not just

187
00:10:08,337 --> 00:10:11,857
Speaker 2: MDMA we mentioned I begain and some of the others ayahuasca.

188
00:10:13,177 --> 00:10:16,977
Speaker 2: That seems to be an impediment that's unnecessary given the

189
00:10:17,017 --> 00:10:18,537
Speaker 2: results that are already being seen.

190
00:10:20,017 --> 00:10:21,497
Speaker 1: So there's a couple of things happening.

191
00:10:21,617 --> 00:10:27,217
Speaker 4: The Breakthrough Therapy's act is looking to reschedule Schedule one

192
00:10:27,257 --> 00:10:31,337
Speaker 4: substances to Schedule two when the FDA deems them a

193
00:10:31,337 --> 00:10:32,137
Speaker 4: breakthrough therapy.

194
00:10:32,217 --> 00:10:33,457
Speaker 1: So breakthrough therapy.

195
00:10:33,217 --> 00:10:40,217
Speaker 4: Designation means that there's great promise through this medication and the.

196
00:10:40,777 --> 00:10:43,297
Speaker 1: FDA will fast track it through the FDA process.

197
00:10:44,457 --> 00:10:47,137
Speaker 4: When it's a Schedule one substance, there's a lot of

198
00:10:47,177 --> 00:10:52,657
Speaker 4: barriers to research. MDMA, for example, receive breakthrough therapy status

199
00:10:52,937 --> 00:10:57,657
Speaker 4: in twenty seventeen, and it's been almost eight years until

200
00:10:57,697 --> 00:10:58,297
Speaker 4: we're going.

201
00:10:58,137 --> 00:11:00,377
Speaker 1: To see it actually be FDA approved.

202
00:11:00,697 --> 00:11:06,217
Speaker 4: So because of those barriers to studying schedule one substances,

203
00:11:07,177 --> 00:11:13,417
Speaker 4: we're seeing a pause in how quickly we can get

204
00:11:13,497 --> 00:11:17,777
Speaker 4: these medications approved and studied. So the Breakthrough Therapy is

205
00:11:17,817 --> 00:11:20,217
Speaker 4: ACT is hoping to correct that so it's easier to

206
00:11:20,337 --> 00:11:26,577
Speaker 4: study substances when they get rescheduled and deemed a breakthrough therapy.

207
00:11:27,257 --> 00:11:28,817
Speaker 1: The other thing that we're doing.

208
00:11:28,817 --> 00:11:32,737
Speaker 4: Is trying to ensure that the VA is ready to

209
00:11:32,857 --> 00:11:35,777
Speaker 4: roll out MDMA assisted therapy in the VA system as

210
00:11:35,817 --> 00:11:40,697
Speaker 4: soon as md A is FDA approved. There you mentioned

211
00:11:40,697 --> 00:11:44,377
Speaker 4: some of these other compounds. They show great promise and

212
00:11:44,417 --> 00:11:49,777
Speaker 4: they're in various various parts of the research funnel. There's

213
00:11:49,817 --> 00:11:53,777
Speaker 4: over I think there's over five hundred different psychedelic compounds

214
00:11:53,777 --> 00:11:55,977
Speaker 4: that are being studied, and it's not just for mental

215
00:11:55,977 --> 00:12:00,097
Speaker 4: health conditions. It's also for pain management for Alzheimer's. There's

216
00:12:00,137 --> 00:12:05,377
Speaker 4: a lot of different ways that these modalities can be

217
00:12:05,457 --> 00:12:07,937
Speaker 4: potentially helpful to a lot of the things that we've

218
00:12:07,977 --> 00:12:09,977
Speaker 4: been lacking answers.

219
00:12:10,697 --> 00:12:13,697
Speaker 2: You mentioned a piece of legislation, Where does that stand

220
00:12:13,777 --> 00:12:17,217
Speaker 2: right now on the hill? And and are you getting

221
00:12:17,257 --> 00:12:19,977
Speaker 2: you know, veterans issues is one of the few areas

222
00:12:20,097 --> 00:12:22,417
Speaker 2: I mean, I you know, we're we're really just focusing

223
00:12:22,417 --> 00:12:24,657
Speaker 2: on your area and your expertise here in my h

224
00:12:25,057 --> 00:12:27,057
Speaker 2: in my day job, you could say, Juliana, I spent

225
00:12:27,097 --> 00:12:29,737
Speaker 2: a lot of time thinking about politics, right, Veterans issue

226
00:12:29,737 --> 00:12:32,257
Speaker 2: is one of the few areas where you can get

227
00:12:32,297 --> 00:12:38,057
Speaker 2: a lot of bipartisan consensus generally speaking. Are you seeing

228
00:12:38,097 --> 00:12:42,737
Speaker 2: that on this issue? Are are both sides equally willing

229
00:12:42,777 --> 00:12:46,937
Speaker 2: to consider some of these these new breakthrough therapies even

230
00:12:46,977 --> 00:12:49,897
Speaker 2: though there's this kind of public stigma about some of

231
00:12:49,897 --> 00:12:52,337
Speaker 2: these substances. Let's be honest. I mean, what's what's the

232
00:12:52,377 --> 00:12:53,577
Speaker 2: temperature like on the hill?

233
00:12:55,177 --> 00:12:58,337
Speaker 4: I think it's the most bipartisan issue on the hill.

234
00:12:59,697 --> 00:13:03,417
Speaker 4: Our legislators have been, like like myself, trying to find

235
00:13:03,457 --> 00:13:06,377
Speaker 4: solutions to the veterans suicide epidemic, and we've been banging

236
00:13:06,377 --> 00:13:08,537
Speaker 4: our heads against the wall because we haven't had any

237
00:13:08,577 --> 00:13:12,457
Speaker 4: solution that actually works. So when I walk into their offices,

238
00:13:12,457 --> 00:13:14,417
Speaker 4: and I show them a solution that two thirds of

239
00:13:14,457 --> 00:13:17,417
Speaker 4: those that go through this treatment no longer qualify for

240
00:13:17,457 --> 00:13:18,897
Speaker 4: a PTSD diagnosis.

241
00:13:19,017 --> 00:13:20,817
Speaker 1: This is the answer that they have been looking for

242
00:13:20,897 --> 00:13:21,337
Speaker 1: as well.

243
00:13:21,737 --> 00:13:26,537
Speaker 4: And so I'm finding very little resistance to getting support

244
00:13:26,737 --> 00:13:31,177
Speaker 4: for ensuring that MDMA assisted therapy is available in the

245
00:13:31,257 --> 00:13:32,297
Speaker 4: VA system.

246
00:13:32,657 --> 00:13:34,617
Speaker 2: Yeah, and I think it's so important for a lot

247
00:13:34,617 --> 00:13:37,257
Speaker 2: of the people listening or watching now know people or

248
00:13:37,257 --> 00:13:42,497
Speaker 2: maybe they themselves have PTSD and if you told any

249
00:13:42,537 --> 00:13:43,977
Speaker 2: of them, and I know this from talking to them

250
00:13:43,977 --> 00:13:47,177
Speaker 2: about it over the course of many years, now that

251
00:13:47,297 --> 00:13:50,417
Speaker 2: they had a two to one hundred chance of really

252
00:13:51,097 --> 00:13:53,177
Speaker 2: getting all the you know, as long as it wasn't

253
00:13:53,217 --> 00:13:55,657
Speaker 2: extremely dangerous or something for they would take that right.

254
00:13:55,737 --> 00:13:57,377
Speaker 3: I mean they would because some.

255
00:13:57,297 --> 00:14:01,297
Speaker 2: Of them haven't found a lot of success with cognitive

256
00:14:01,337 --> 00:14:04,457
Speaker 2: therapy alone. Some of them still struggle with the flashbacks

257
00:14:04,457 --> 00:14:06,297
Speaker 2: and things like that. So when you're talking about a

258
00:14:06,297 --> 00:14:09,457
Speaker 2: two out of three shot, I think that that just

259
00:14:09,497 --> 00:14:12,937
Speaker 2: goes to show how promising this is and what a

260
00:14:12,937 --> 00:14:15,297
Speaker 2: breakthrough this could be. Just taking a moment here for

261
00:14:15,297 --> 00:14:18,377
Speaker 2: the TUNNELA Towers Foundation, an organization does a tremendous amount

262
00:14:18,417 --> 00:14:20,457
Speaker 2: of good and make sure and make sure that we

263
00:14:20,537 --> 00:14:23,177
Speaker 2: never forget. This means never forgetting nine to eleven, never

264
00:14:23,217 --> 00:14:25,497
Speaker 2: forgetting the soldiers and first responders who risk their lives

265
00:14:25,537 --> 00:14:28,777
Speaker 2: in bodies for our country and communities. The foundation is

266
00:14:28,777 --> 00:14:31,417
Speaker 2: committed to helping these heroes and their families. Heroes like

267
00:14:31,657 --> 00:14:35,537
Speaker 2: retired Air Force Lieutenant Michael Cardo's Lieutenant Cardinal Cardos served

268
00:14:35,537 --> 00:14:38,497
Speaker 2: his country for twenty years and received numerous commendations, including

269
00:14:38,497 --> 00:14:41,297
Speaker 2: a Bronze Star. During his time overseas, he was exposed

270
00:14:41,297 --> 00:14:44,097
Speaker 2: to toxic burn pits. Eighteen hours after being diagnosed with

271
00:14:44,137 --> 00:14:47,777
Speaker 2: service related cancer, he passed away. Tune the Towers paid

272
00:14:47,817 --> 00:14:50,617
Speaker 2: off the mortgage on his family's home, enabling his widow

273
00:14:50,617 --> 00:14:53,017
Speaker 2: and their six children to stay in that home, removing

274
00:14:53,017 --> 00:14:56,217
Speaker 2: that financial burden. The foundation helps gold Star families and

275
00:14:56,257 --> 00:14:58,857
Speaker 2: the families of fall and first responders, as well as

276
00:14:58,857 --> 00:15:02,577
Speaker 2: catastrophically injured heroes and homeless veterans. Help families like the

277
00:15:02,657 --> 00:15:05,697
Speaker 2: Cardos donate eleven dollars a month. Tunnel the Towers at

278
00:15:05,697 --> 00:15:08,057
Speaker 2: T two T dot org. That's t the number two

279
00:15:08,137 --> 00:15:08,817
Speaker 2: T dot org.

280
00:15:08,857 --> 00:15:10,697
Speaker 3: I donate every month. It's really easy, you can set

281
00:15:10,737 --> 00:15:11,537
Speaker 3: it up. It's recurring.

282
00:15:11,817 --> 00:15:13,737
Speaker 2: Please team join me in this one T two T

283
00:15:13,977 --> 00:15:19,137
Speaker 2: dot org. Juliana, thank you for telling us all about this.

284
00:15:19,257 --> 00:15:20,857
Speaker 2: I know you're you're on the hill and you're trying

285
00:15:20,897 --> 00:15:23,897
Speaker 2: to move the ball forward with legislation. For anybody who's

286
00:15:23,897 --> 00:15:27,017
Speaker 2: interested either in just learning more or also perhaps helping

287
00:15:27,057 --> 00:15:30,977
Speaker 2: out or maybe finding some of the resources that could

288
00:15:30,977 --> 00:15:33,777
Speaker 2: be available to them if they themselves have a service

289
00:15:33,777 --> 00:15:37,017
Speaker 2: related PTSD, where can people go and how can they

290
00:15:37,057 --> 00:15:37,617
Speaker 2: get involved?

291
00:15:39,417 --> 00:15:43,617
Speaker 4: Healing Breakthrough dot org for more information. If you're interested

292
00:15:43,697 --> 00:15:47,457
Speaker 4: in the clinical trials, it's a clinicaltrials dot gov. And

293
00:15:47,497 --> 00:15:51,617
Speaker 4: if you're a veteran that is looking to connect with

294
00:15:51,777 --> 00:15:55,217
Speaker 4: these therapies, Heroicheartsproject dot org.

295
00:15:56,137 --> 00:15:58,697
Speaker 2: All Right, there we go. Juanna, thank you again for

296
00:15:58,697 --> 00:16:00,457
Speaker 2: your service and your time today. We appreciate it.

297
00:16:00,577 --> 00:16:01,977
Speaker 1: Thank you. Buck, great talking to you.

298
00:16:02,337 --> 00:16:02,897
Speaker 3: Thank you.